Published in Cancer Res on July 01, 1979
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65
Editorial: Measurement of delayed skin-test responses. N Engl J Med (1975) 2.99
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis (1993) 1.76
Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. J Lab Clin Med (1973) 1.75
An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer (1987) 1.72
Splenic abscesses from 1987 to 1995. Am J Surg (1997) 1.67
Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med (1970) 1.56
Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro (1982) 1.39
Concurrent chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the oesophagus: a single centre experience. Ann Acad Med Singapore (2005) 1.38
Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes (1969) 1.34
Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors. J Natl Cancer Inst (1975) 1.30
Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer (2003) 1.29
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann Oncol (2009) 1.27
HIV, trauma, and infection control: universal precautions are universally ignored. J Trauma (1990) 1.25
In vitro lymphocyte response to autologous cultured lymphoid cells. Proc Soc Exp Biol Med (1971) 1.20
Complications of BCG vaccination in neoplastic disease. Ann Intern Med (1975) 1.16
Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines. Cancer Res (1972) 1.15
A simplified technique for in vitro studies of lymphocyte reactivity. Proc Soc Exp Biol Med (1972) 1.12
"Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes. Am J Med (1972) 1.11
Immunotherapy in well-controlled chronic myelocytic leukemia. N Y State J Med (1973) 1.10
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol (2002) 1.08
Primary prostatic involvement in non-Hodgkin lymphoma. Urology (1988) 1.07
Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide. Biochem Biophys Res Commun (1984) 1.06
Salmonellosis in disseminated malignant diseases. A seven-- year review (1959-1965). N Engl J Med (1967) 1.05
Glucagon--an essential hormone. Am J Med (1966) 1.05
Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. J Immunol (1978) 1.05
Acute appendicitis during pregnancy. Diagnosis and management. Arch Surg (1985) 1.04
Continuous arteriovenous rewarming: experimental results and thermodynamic model simulation of treatment for hypothermia. J Trauma (1990) 1.02
Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann Intern Med (1970) 1.01
Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology (1966) 1.01
Mycoplasmas (PPLO) and human leukemia and lymphoma. Cancer (1965) 1.01
Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst (1981) 1.00
Fatal blunt aortic injuries: a review of 242 autopsy cases. J Trauma (2001) 1.00
Delay in progression of malignant lymphoma after BCG vaccination. N Engl J Med (1974) 0.97
Second neoplasms with chronic lymphocytic leukemia. N Y State J Med (1976) 0.97
Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood (1984) 0.97
The use of an absorbable mesh wrap in the management of major liver injuries. Surgery (1992) 0.96
Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol (1984) 0.95
Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem (1985) 0.95
A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma. Ann Oncol (2011) 0.94
Production, purification and clinical application of human fibroblast interferon. Pharmacol Ther (1980) 0.94
Yunnanxane and its homologous esters from cell cultures of Taxus chinensis var. mairei. J Nat Prod (1994) 0.94
Terminal deoxynucleotidyl transferase activity in blastic phase of chronic myelogenous leukemia. Cancer Res (1977) 0.94
Pyrogen in the urine of febrile patients with Hodgkin's disease. Nature (1967) 0.93
Penetrating chest trauma: should indications for emergency room thoracotomy be limited? Am Surg (1996) 0.92
An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues. Mol Pharmacol (1976) 0.92
Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts. Infect Immun (1978) 0.91
Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease. Int J Cancer (1973) 0.91
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma. Ann Oncol (2010) 0.90
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood (1988) 0.90
Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. Endocrinology (1970) 0.90
Basal plasma glucagon levels of man. J Clin Invest (1967) 0.90
Response to BCG vaccination and survival in advanced Hodgkin's disease. Cancer (1969) 0.89
Cellular immune responses and prognosis in malignant lymphomas. Natl Cancer Inst Monogr (1971) 0.89
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood (1985) 0.89
Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate (1991) 0.88
A prospective evaluation of field categorization of trauma patients. J Trauma (1988) 0.88
Human medullary thyroid carcinoma in culture provides a model relating growth dynamics, endocrine cell differentiation, and tumor progression. J Clin Endocrinol Metab (1984) 0.88
Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. Ann Intern Med (1969) 0.87
Surgical cricothyroidotomy in trauma patients: analysis of its use by paramedics in the field. J Trauma (1996) 0.87
Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines. J Immunol (1975) 0.86
Negative appendix with suspected appendicitis: an update. South Med J (1986) 0.85
Suspected vascular trauma of the extremities: the role of arteriography in proximity injuries. J Trauma (1986) 0.85
Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. N Engl J Med (1984) 0.85
Effect of glucagon on phosphorylase activity of the isolated perfused liver. Am J Physiol (1969) 0.85
Comparison of glucagon and epinephrine effects in the dog. Endocrinology (1966) 0.85
Bioassay of glucagon using the isolated perfused rat liver. Endocrinology (1970) 0.84
Long survival in Hodgkin's disease. Am J Med (1970) 0.84
Correlation of delayed hypersensitivity responses with chemotherapeutic results in advanced Hodgkin's disease. Cancer (1975) 0.84
Antivirion effects of streptovaricin complex against Friend virus. Antimicrob Agents Chemother (1974) 0.84
Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. Cancer Res (1986) 0.83
Noncycling tumor cells are sensitive targets for the antiproliferative activity of human interferon. Science (1979) 0.83
Immunotherapy of chronic myelocytic leukemia. Natl Cancer Inst Monogr (1973) 0.83
Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results. Int J Radiat Oncol Biol Phys (1999) 0.82
Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy. J Surg Oncol (1973) 0.82
Current helmet and protective equipment usage among previously injured ATV and motorcycle riders. Inj Prev (2004) 0.82
Selective use of computed tomography and diagnostic peritoneal lavage in blunt abdominal trauma. J Trauma (1995) 0.82
Meandering bullet in the pericardial sac: to remove or not to remove. Am Surg (1998) 0.82
Complete remission in chronic lymphocytic leukemia and leukolymphosarcoma. Cancer (1967) 0.82
Acute tumor lysis syndrome in prolymphocytic leukemia. Arch Intern Med (1987) 0.82
Xanthine nephropathy during chemotherapy in deficiency of hypoxanthine-guanine phosphoribosyltransferase. Arch Intern Med (1978) 0.82
Evaluation of survival data for chronic myelocytic leukemia. Am J Hematol (1976) 0.81
Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer (1988) 0.81
Diagnostic peritoneal lavage in the management of blunt abdominal trauma: a reassessment. J Trauma (1987) 0.80
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients. Prostate (1994) 0.80
Sulfapyridine-induced serum-sickness-like syndrome associated with plasmacytosis, lymphocytosis and multiclonal gamma-globulinopathy. N Engl J Med (1969) 0.80